Tanvex BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 6541?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,383,8011.45%
Public Companies5,767,0393.51%
Institutions8,817,4465.37%
Private Companies58,979,44735.9%
General Public88,123,63453.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.6%.


Top Shareholders

Top 14 shareholders own 46.29% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.4%
Penglin Investment Co., Ltd.
23,539,537NT$1.6b0%no data
7.69%
Tanvex Biologics, Inc.
12,613,108NT$859.0m0%no data
5.18%
Allen Chao And Lee Hwa Chao Family Trust
8,498,839NT$578.8m0%no data
3.76%
Huei Hong Investment Co., Ltd.
6,162,074NT$419.6m0%no data
3.68%
Renying Industrial Co., Ltd.
6,035,930NT$411.0m0%no data
3.51%
Ruentex Industries Ltd.
5,767,039NT$392.7m0%no data
2.93%
Delos Advisors Limited
4,803,510NT$327.1m0%100.0%
1.3%
Chang Chuen Investment Co., Ltd.
2,129,959NT$145.1m0%no data
1.22%
Fubon Life Insurance Co., Ltd., Asset Management Arm
2,007,804NT$136.7m0%0.03%
1.22%
Fubon Financial Holding Venture Capital Co., Ltd.
2,006,132NT$136.6m0%2.06%
0.87%
Allen Chao
1,429,873NT$97.4m0%no data
0.5%
David Hsia
814,738NT$55.5m0%no data
0.075%
Yun Yen
122,830NT$8.4m0%no data
0.01%
Chi-Chuan Chen
16,360NT$1.1m0%no data